STAT
JULY 22, 2024
The report , which was released in March but received little if any public attention, examined drug spending between 2016 and 2021 within the health plan that covers more than 200,000 unionized mail carriers and post office workers, as well as retirees.
STAT
JANUARY 10, 2024
This latest revision, known as the DSM-5-TR, was prepared between 2016 and 2019, and published in 2022. The researchers found that, of the 55 physicians with ties to a pharmaceutical company, 91% accepted food and beverages, and 69% received compensation for travel and consulting, according to the analysis published in the BMJ.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MAY 11, 2023
Thanks to changes in tax law six years ago, several of the largest pharmaceutical companies saw their tax rates fall substantially, but they also reported that most of their profits were shifted offshore in an effort to avoid paying U.S. taxes, according to a memo by a U.S. Senate Committee. in 2020, down from 19.6%
Pharmaceutical Technology
JULY 19, 2022
In total, the frequency of sentences related to cloud computing between April 2021 and March 2022 was 133% higher than in 2016 when GlobalData, from whom our data for this article is taken, first began to track the key issues referred to in company filings. Other top employers with high cloud mentions included GSK, Roche and Pfizer.
European Pharmaceutical Review
JUNE 26, 2024
In 2016, the company announced a new facility, the single largest life sciences investment in North Carolina at the time, Butch Lawter , Chair of the Johnston County Board of Commissioners, US, explained during a press conference. This is compared to the company’s $3.9 (DKK Completion is expected between 2027 and 2029.
European Pharmaceutical Review
AUGUST 9, 2023
While injectable biologic therapies are an effective option for CSU that is uncontrolled by these drugs, less than 20 percent of patients worldwide are treated with them, according to a 2016 British Journal of Dermatology paper and research shared by Novartis. There were 470 participants in the REMIX-1 study.
pharmaphorum
OCTOBER 20, 2020
The pandemic has triggered a change in how pharmaceutical companies are engaging with healthcare professionals. When IQVIA polled non COVID-19 treating Italian HCPs in March when the crisis was at its worst, it asked HCPs if they still welcomed pharmaceutical company engagement during the crisis. The answer was yes.
Expert insights. Personalized for you.
145 
Let's personalize your content